Defining High-risk Retinoblastoma

Author:

Kaliki Swathi1,Shields Carol L.2,Cassoux Nathalie3,Munier Francis L.4,Chantada Guillermo5,Grossniklaus Hans E.6,Yoshikawa Hiroshi7,Fabian Ido Didi8,Berry Jesse L.9,McKenzie John D.10,Kimani Kahaki11,Reddy M. Ashwin12,Parulekar Manoj13,Tanabe Mika7,Furuta Minoru14,Grigorovski Natalia15,Chevez-Barrios Patricia16,Scanlan Patricia17,Eagle Ralph C.18,Rashid Riffat19,Coronado Rosdali Díaz20,Sultana Sadia19,Staffieri Sandra102122,Frenkel Shahar23,Suzuki Shigenobu24,Ushakova Tatiana L.2526,Ji Xunda27

Affiliation:

1. Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute India, Hyderabad, India

2. Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania

3. Department of Surgical Oncology, Insitut Curie Université de Paris, Paris, France

4. Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland

5. Oncology Department, Hospital Sant Joan de Déu, Barcelona, Spain

6. Department of Pathology, Emory University School of Medicine, Atlanta, Georgia

7. Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

8. Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel-Aviv University, Tel-Aviv, Israel

9. USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles

10. Department of Ophthalmology, Royal Children’s Hospital, Melbourne, Victoria, Australia

11. Department of Ophthalmology, University of Nairobi, Nairobi, Kenya

12. Retinoblastoma Service, Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom

13. Retinoblastoma Service, Birmingham Women’s and Children’s National Health Service Foundation Trust, Birmingham, United Kingdom

14. Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan

15. Department of Pediatric Oncology, Clinical Division, National Institute of Cancer, Rio de Janeiro, Brazil

16. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas

17. Department of Pediatrics, Muhimbili National Hospital, Dar es Salaam, Tanzania

18. Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania

19. Department of Oculoplasty and Ocular Oncology, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh

20. Retinoblastoma Service, Instituto Nacional de Enfermedades Neoplasicas, Lima, Perú

21. Retinoblastoma Service, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia

22. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia

23. Division of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

24. Department of Ophthalmic Oncology, National Cancer Center Hospital, Tokyo, Japan

25. Department of Pediatric Oncology and Hematology, N. N. Blokhin National Medical Research Center Oncology of Russian Federation, Moscow, Russia

26. Retinoblastoma Service, Medical Academy of Postgraduate Education, Moscow, Russia

27. Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3